KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Financing Activities: 2010-2025

Historic Cash from Financing Activities for Opko Health (OPK) over the last 15 years, with Sep 2025 value amounting to -$16.2 million.

  • Opko Health's Cash from Financing Activities fell 107.86% to -$16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$140.2 million, marking a year-over-year decrease of 163.47%. This contributed to the annual value of $184.2 million for FY2024, which is 1729.36% up from last year.
  • Opko Health's Cash from Financing Activities amounted to -$16.2 million in Q3 2025, which was up 79.61% from -$79.5 million recorded in Q2 2025.
  • Opko Health's 5-year Cash from Financing Activities high stood at $206.1 million for Q3 2024, and its period low was -$79.5 million during Q2 2025.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$3.8 million (2023), whereas its average is $6.6 million.
  • As far as peak fluctuations go, Opko Health's Cash from Financing Activities skyrocketed by 9,692.87% in 2024, and later tumbled by 3,658.35% in 2025.
  • Over the past 5 years, Opko Health's Cash from Financing Activities (Quarterly) stood at $833,000 in 2021, then spiked by 1,117.77% to $10.1 million in 2022, then plummeted by 136.98% to -$3.8 million in 2023, then plummeted by 978.97% to -$40.5 million in 2024, then plummeted by 107.86% to -$16.2 million in 2025.
  • Its Cash from Financing Activities stands at -$16.2 million for Q3 2025, versus -$79.5 million for Q2 2025 and -$4.0 million for Q1 2025.